Zenas Biopharma, Inc. · NASDAQ:ZBIO
SR One Capital Management, LLC reported a 9.40% stake in Zenas Biopharma, Inc. (Schedule 13D/A)
Event Oct 9, 2025 · Filed Oct 14, 2025
SR One Capital Management, LLC reported a 9.40% stake in Zenas Biopharma, Inc., 5,037,854 shares, with active intent on Oct 9, 2025. Filed Oct 14, 2025 (Schedule 13D/A).
- Stake
- 9.40%
- Shares
- 5,037,854
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SR One Capital Management, LLC | 9.40% | 5,037,854 |
| SR One Capital Fund II Aggregator, LP | 3.60% | 1,946,564 |
| SR One Capital Partners II, LP | 3.60% | 1,946,564 |
| AMZL, LP | 3.60% | 1,917,895 |
| SR One Capital SMA Partners, LP | 3.60% | 1,917,895 |
| SR One Capital Opportunities Fund I, LP | 2.20% | 1,173,395 |
| SR One Capital Opportunities Partners I, LP | 2.20% | 1,173,395 |
| Simeon George | 9.40% | 5,037,854 |
Source
Related
- Zenas Biopharma, Inc.
- SR One Capital Management, LLC
- Zenas Biopharma, Inc. shareholders
- Schedule 13D/A · SR One Capital Management, LLC · Aug 17, 2026
- Schedule 13G · Wellington Management Group LLP · Sep 8, 2026
- Schedule 13G/A · InnoCare Pharma Inc. · Sep 8, 2026
- Schedule 13D/A · Enavate Sciences Gp, LLC · Aug 19, 2026
- Form 4 · Farmer Joseph L · Jun 17, 2026
- Form 4 · Fox Jennifer A. · Jun 17, 2026